United States Securities and Exchange Commission · EDGAR Accession 0002053710-26-000002

Form C-AR

Annual Report — Regulation Crowdfunding
Issuer CIK 2053710
Period 2025-12-31

RAM Pharmaceuticals Inc.

CorporationMSIncorporated 2024LUMBERTON, MSrampharmaceuticals.com
B

Financial Condition

two fiscal years, as filed
Pre-revenueDebt / assets 220%1 employee
Line itemMost recent FYPrior FYΔ
Revenue00
Cost of goods sold00
Net income(33,481)0
Total assets27,8570
Cash & equivalents23,4380
Accounts receivable7,4450
Short-term debt61,3380
Long-term debt00
Taxes paid00

Figures in USD as reported by the issuer.